Boston Scientific Overview
Boston Scientific Target Price
Analysts' 12-month price predictions for BSX.
Get informed when a big investor buys or sells
+ FollowShare Price
$45.6
Average Target Price
$78.73
72.7% upside
72.7% upside26 analysts in the last 4 months
High: $100 | Low: $55
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-12 | Piper Sandler | $65 | 42.5% upside |  |
| 2026-06-04 | Truist Financial | $64 | 40.4% upside | |
| 2026-06-02 | BTIGMarie Thibault | $65 | 42.5% upside | |
| 2026-06-01 | Canaccord Genuity | $70 | 53.5% upside | |
| 2026-05-28 | Goldman Sachs | $71 | 55.7% upside | |
| 2026-05-28 | Robert W. Baird | $70 | 53.5% upside | |
| 2026-05-28 | Leerink PartnersMike Kratky | $74 | 62.3% upside | |
| 2026-05-28 | Barclays | $89 | 95.2% upside | |
| 2026-05-28 | Wells FargoLarry Biegelsen | $55 | 20.6% upside | |
| 2026-05-27 | Stifel NicolausRick Wise | $75 | 64.5% upside | |
| 2026-05-19 | Robert W. Baird | $75 | 64.5% upside | |
| 2026-04-29 | Daiwa | $60 | 31.6% upside | |
| 2026-04-23 | Oppenheimer | $90 | 97.4% upside | |
| 2026-04-23 | RBC Capital | $100 | 119.3% upside | |
| 2026-04-23 | Canaccord GenuityWilliam Plovanic | $71 | 55.7% upside | |
| 2026-04-23 | BarclaysMatt Miksic | $96 | 110.5% upside | |
| 2026-04-23 | Wells Fargo | $75 | 64.5% upside | |
| 2026-04-23 | Truist Financial | $85 | 86.4% upside | |
| 2026-04-23 | Robert W. Baird | $78 | 71.1% upside | |
| 2026-04-23 | NeedhamMike Matson | $77 | 68.9% upside | |
| 2026-04-22 | JefferiesMatthew Taylor | $100 | 119.3% upside | |
| 2026-04-22 | Goldman SachsDavid Roman | $84 | 84.2% upside | |
| 2026-04-21 | Stifel NicolausRick Wise | $85 | 86.4% upside | |
| 2026-04-15 | Truist Financial | $90 | 97.4% upside | |
| 2026-04-13 | Mizuho Securities | $90 | 97.4% upside | |
| 2026-03-26 | Goldman Sachs | $93 | 103.9% upside | |
| 2026-02-17 | Canaccord GenuityWilliam Plovanic | $109 | 139% upside | |
| 2026-02-06 | BernsteinLee Hambright | $112 | 145.6% upside | |
| 2026-02-05 | RBC Capital | $115 | 152.2% upside | |
| 2026-02-05 | Truist Financial | $95 | 108.3% upside | |
| 2026-02-05 | Needham | $97 | 112.7% upside | |
| 2026-02-05 | UBS | $120 | 163.2% upside | |
| 2026-02-05 | Robert W. Baird | $101 | 121.5% upside | |
| 2026-02-05 | Goldman Sachs | $99 | 117.1% upside | |
| 2026-02-05 | Wells Fargo | $94 | 106.1% upside | |
| 2026-02-05 | Evercore ISI | $96 | 110.5% upside | |
| 2026-02-05 | Mizuho Securities | $115 | 152.2% upside | |
| 2026-02-05 | Canaccord GenuityWilliam Plovanic | $112 | 145.6% upside | |
| 2026-02-04 | BTIG | $110 | 141.2% upside | |
| 2026-02-04 | Stifel NicolausRick Wise | $110 | 141.2% upside | |
| 2026-02-03 | Barclays | $124 | 171.9% upside | |
| 2026-02-02 | National Bank | $115 | 152.2% upside | |
| 2026-01-16 | Oppenheimer | $100 | 119.3% upside | |
| 2026-01-09 | Goldman SachsDavid Roman | $112 | 145.6% upside | |
| 2026-01-05 | Evercore ISI | $112 | 145.6% upside | |
| 2025-12-18 | Truist Financial | $120 | 163.2% upside | |
| 2025-12-17 | Canaccord GenuityWilliam Plovanic | $131 | 187.3% upside | |
| 2025-12-17 | RBC Capital | $130 | 185.1% upside | |
| 2025-10-23 | Truist Financial | $130 | 185.1% upside | |
| 2025-10-23 | Morgan StanleyPatrick Wood | $130 | 185.1% upside | |